Riltrava Aerosphere Eiropas Savienība - latviešu - EMA (European Medicines Agency)

riltrava aerosphere

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - plaušu slimība, hroniska obstruktīva - zāles obstruktīvu elpceļu slimību, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.

Dexamethasone Krka 20 mg tabletes Latvija - latviešu - Zāļu valsts aģentūra

dexamethasone krka 20 mg tabletes

krka, d.d., novo mesto, slovenia - deksametazons - tablete - 20 mg

Dermovate 0,5 mg/g krēms Latvija - latviešu - Zāļu valsts aģentūra

dermovate 0,5 mg/g krēms

glaxosmithkline (ireland) limited, ireland - klobetazola propionāts - krēms - 0,5 mg/g

Dermovate 0,5 mg/g krēms Latvija - latviešu - Zāļu valsts aģentūra

dermovate 0,5 mg/g krēms

glaxosmithkline (ireland) limited, ireland - klobetazola propionāts - krēms - 0,5 mg/g

Dermovate 0,5 mg/g ziede Latvija - latviešu - Zāļu valsts aģentūra

dermovate 0,5 mg/g ziede

glaxosmithkline (ireland) limited, ireland - klobetazola propionāts - ziede - 0,5 mg/g

Ximluci Eiropas Savienība - latviešu - EMA (European Medicines Agency)

ximluci

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmoloģiskie līdzekļi - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Ranivisio Eiropas Savienība - latviešu - EMA (European Medicines Agency)

ranivisio

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmoloģiskie līdzekļi - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).

Dermovate 0,5 mg/g ziede Latvija - latviešu - Zāļu valsts aģentūra

dermovate 0,5 mg/g ziede

glaxosmithkline (ireland) limited, ireland - klobetazola propionāts - ziede - 0,5 mg/g

Tadalafil Zentiva 20 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

tadalafil zentiva 20 mg apvalkotās tabletes

zentiva, k.s., czech republic - tadalafils - apvalkotā tablete - 20 mg

Tadalafil STADA 10 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

tadalafil stada 10 mg apvalkotās tabletes

stada arzneimittel ag, germany - tadalafils - apvalkotā tablete - 10 mg